The next controversy in genetic testing: Clinical data as trade secrets? Read more about The next controversy in genetic testing: Clinical data as trade secrets?
Gene patenting--the Supreme Court finally speaks Read more about Gene patenting--the Supreme Court finally speaks
AMP v. Myriad: A surgical strike on Blockbuster business models Read more about AMP v. Myriad: A surgical strike on Blockbuster business models
Cell-free fetal DNA testing: Who is driving implementation? Read more about Cell-free fetal DNA testing: Who is driving implementation?
The emergence of commercial genomics: Analysis of the rise of a biotechnology subsector during the Human Genome Project, 1990 to 2004 Read more about The emergence of commercial genomics: Analysis of the rise of a biotechnology subsector during the Human Genome Project, 1990 to 2004
Improving (software) patent quality through the administrative process Read more about Improving (software) patent quality through the administrative process
Myriad after Myriad: The proprietary data dilemma Read more about Myriad after Myriad: The proprietary data dilemma
Interpreting genetics in the context of eating disorders: Evidence of disease, not diversity Read more about Interpreting genetics in the context of eating disorders: Evidence of disease, not diversity
Distributing the future: The weak justifications for keeping human genomic databases secret and the challenges and opportunities in reverse engineering them Read more about Distributing the future: The weak justifications for keeping human genomic databases secret and the challenges and opportunities in reverse engineering them
